Excess costs of non-infectious comorbidities among people living with HIV - estimates from Denmark and Sweden

AIDS Care
Frida HjaltePeter Lindgren

Abstract

People living with HIV have an increased risk of comorbidities with non-communicable diseases such as cardiovascular disease, chronic kidney disease and osteoporotic fractures, compared to the general population. The burden of these comorbidities is expected to rise as the HIV-infected population ages. This development may require additional health care resources and it is relevant to ascertain the costs associated with these comorbidities. The population attributed risk approach was applied to estimate excess costs associated with the higher rates of comorbidities among HIV patients in Denmark and Sweden compared to their respective general populations. Excess direct and indirect costs for one year were calculated for myocardial infarction, stroke, osteoporotic fractures and chronic kidney disease. Cost estimates were presented in age and sex subgroups. In the course of one year the excess costs for myocardial infarction, stroke, osteoporotic fractures and chronic kidney disease attributable to HIV was estimated to €3.4 million for Denmark and €2.6 million for Sweden. Chronic kidney disease accounted for the majority of the total excess costs, followed by osteoporotic fractures, myocardial infarction and stroke. The high preva...Continue Reading

References

Apr 17, 1998·Obesity Research·A M Wolf, G A Colditz
Feb 20, 2008·International Journal of Pediatric Obesity : IJPO : an Official Journal of the International Association for the Study of Obesity·Knut OdegaardMarianne Svensson
Oct 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Giovanni GuaraldiFrank Palella
Feb 20, 2013·Archives of Osteoporosis·Louise HansenKarin D Petersen
Aug 27, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Magnus G RaschNiels Obel
Oct 8, 2013·ClinicoEconomics and Outcomes Research : CEOR·Giovanni GuaraldiFrank Palella
Oct 11, 2013·BMC Health Services Research·Ghassan MouradTiny Jaarsma
May 16, 2014·Current Opinion in HIV and AIDS·Peter W Hunt
Jun 5, 2014·International Journal of Technology Assessment in Health Care·Ola GhatnekarEva-Lotta Glader
Jul 31, 2014·International Journal of Epidemiology·Lars Haukali OmlandNiels Obel
Sep 4, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Judith SchoutenUNKNOWN AGEhIV Cohort Study Group
Jan 18, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Line D RasmussenNiels Obel
Jul 26, 2015·Health Economics Review·Marta Trapero-Bertran, Juan Oliva-Moreno
Oct 16, 2015·BMC Health Services Research·Poul JennumJakob Kjellberg
Jun 22, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marie JakobsenSøren P Johnsen
Sep 27, 2016·The Lancet Infectious Diseases·Brooke E NicholsDavid A M C van de Vijver
Oct 16, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alessandro GaspariniJuan-Jesüs Carrero
Nov 16, 2016·Clinical Epidemiology·Søren Paaske JohnsenJesper Gyllenborg

❮ Previous
Next ❯

Citations

Dec 7, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jakob Starup-LindeBente Langdahl
Jan 1, 2020·EClinicalMedicine·Sumedha ChhatreRavishankar Jayadevappa
Oct 30, 2020·Microorganisms·Frank DenaroDavide Zella

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

ClinicoEconomics and Outcomes Research : CEOR
Giovanni GuaraldiFrank Palella
Medicina clínica
Ferrán Catalá-López, Ricard Gènova-Maleras
Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
A Diener, J Dugas
© 2022 Meta ULC. All rights reserved